Viyash Scientific · NSE: VIYASH · BSE: 512529
Q3 FY23 results · Oct–Dec 2022
Viyash Scientific reported revenue from operations of ₹375.31 crore (up 4.8% from Q3 FY22) and net loss of ₹9.78 crore for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 375.31 | 358.05 | +4.8% | 337.61 | +11.2% |
| Other income | 2.86 | 3.67 | −21.9% | 0.91 | +214.3% |
| Total income | 378.18 | 361.71 | +4.6% | 338.52 | +11.7% |
| Profit before tax | (10.20) | 23.61 | Turned loss | (17.72) | Loss narrowed |
| Net profit for the period | (9.78) | 18.56 | Turned loss | (4.44) | Loss widened |
| Attributable to shareholders of the company | (8.87) | 17.12 | Turned loss | (3.75) | Loss widened |
| EPS, basic (₹) | (0.36) | 0.69 | Turned loss | (0.15) | Loss widened |
| Net margin (%) | -2.6 | 5.2 | -1.3 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 57.00 | 59.19 | −3.7% | 54.23 | +5.1% |
| Other income | 7.62 | 5.70 | +33.8% | 6.73 | +13.3% |
| Total income | 64.62 | 64.89 | −0.4% | 60.96 | +6.0% |
| Profit before tax | (3.99) | 5.52 | Turned loss | (5.68) | Loss narrowed |
| Net profit for the period | (1.23) | 4.47 | Turned loss | (4.05) | Loss narrowed |
| EPS, basic (₹) | (0.05) | 0.18 | Turned loss | (0.16) | Loss narrowed |
| Net margin (%) | -2.1 | 7.6 | -7.5 |
Consolidated
- Filed with BSE
- 15 Feb 2023, 18:12 IST
- Board meeting
- 14 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 15 Feb 2023, 18:12 IST
- Board meeting
- 14 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE